ATP5F1A and Alzheimer disease: For AD, ATP5F1A (Importance 17.7), a mitochondrial ATP synthase subunit critical for energy production, was associated with Aurovertin B (PUBCHEM_CID: 444853), an F1F0-ATPase inhibitor that could modulate ATP synthesis in cognitive decline.